Inflammation and plaque vulnerability

PK Shah - Cardiovascular drugs and therapy, 2009 - Springer
Abstract Development of a thrombus at the site of an atherosclerotic plaque initiates abrupt
arterial occlusion and is the proximate event responsible for the vast majority of acute …

Molecular mechanisms of plaque instability

PK Shah - Current opinion in lipidology, 2007 - journals.lww.com
Molecular mechanisms of plaque instability : Current Opinion in Lipidology Molecular
mechanisms of plaque instability : Current Opinion in Lipidology Log in or Register Subscribe …

High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease

NK Kapur, D Ashen, RS Blumenthal - Vascular health and risk …, 2008 - Taylor & Francis
Since the pioneering work of John Gofman in the 1950s, our understanding of high density
lipoprotein cholesterol (HDL-C) and its relationship to coronary heart disease (CHD) has …

Anacetrapib, a novel CETP inhibitor: pursuing a new approach to cardiovascular risk reduction

DE Gutstein, R Krishna, D Johns… - Clinical …, 2012 - Wiley Online Library
Cholesteryl ester transfer protein (CETP) inhibition is a promising experimental strategy to
raise high‐density lipoprotein cholesterol (HDL‐C) and reduce cardiovascular risk. This …

HDL, ApoA-I and ApoE-mimetic peptides: potential broad spectrum agent for clinical use?

SA Nankar, PS Kawathe, AH Pande - International Journal of Peptide …, 2022 - Springer
Peptides mimicking the biological properties of apolipoproteins have shown beneficial
properties against a variety of diseases and have emerged as a potential candidate for their …

[HTML][HTML] D4F prophylaxis enables redox and energy homeostasis while preventing inflammation during hypoxia exposure

S Paul, A Gangwar, K Bhargava, Y Ahmad - Biomedicine & …, 2021 - Elsevier
Apo-A1 is correlated with conditions like hyperlipidemia, cardiovascular diseases, high
altitude pulmonary edema and etc. where hypoxia constitutes an important facet. Hypoxia …

Evolving concepts on benefits and risks associated with therapeutic strategies to raise HDL

PK Shah - Current opinion in cardiology, 2010 - journals.lww.com
Evolving concepts on benefits and risks associated with ther... : Current Opinion in Cardiology
Evolving concepts on benefits and risks associated with therapeutic strategies to raise HDL …

[PDF][PDF] Residual risk and high-density lipoprotein cholesterol levels: is there a relationship?

PK Shah - Reviews in cardiovascular medicine, 2011 - article.imrpress.com
Statins reduce adverse cardiovascular events in both primary and secondary prevention
settings. Despite their use, however, a residual burden of cardiovascular events continues to …

Patient considerations and clinical impact of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia: focus on anacetrapib

MA Miyares, K Davis - Vascular health and risk management, 2012 - Taylor & Francis
Cardiovascular disease (CVD) is responsible for significant morbidity and mortality within
the United States and worldwide. Although targeting low-density lipoprotein cholesterol …

[PDF][PDF] Humoral response towards high-density lipoprotein: a new mechanism for atherogenesis

JR Batuca - 2013 - core.ac.uk
The first thankfulness goes to my supervisor Prof. Doutor José Delgado Alves, for his
consistent guidance into the scientific way of thinking, encouragement and support. Above of …